Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Expert Opinion on Pharmacotherapy|April 29, 2009
Effects of long chain omega-3 fatty acids on metalloproteinases and their inhibitors in combined dyslipidemia patientsG Derosa, P Maffioli, A D'Angelo, et al.
Journal of Clinical Pharmacy and Therapeutics|September 14, 2010
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metforminG Derosa, R Mereu, A D'Angelo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Fotemustine and dacarbazine plus recombinant interferon alpha 2a in thetreatment of advanced melanomaP Comella, A Daponte, R Casaretti, et al.
Journal of Clinical Pharmacy and Therapeutics|May 11, 2007
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazoneG Derosa, E Fogari, A D'Angelo, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|September 8, 2009
Oral glucose tolerance test effects on endothelial inflammation markers in healthy subjects and diabetic patientsG Derosa, A D'Angelo, S A T Salvadeo, et al.
Endothelium : Journal of Endothelial Cell Research|July 30, 2008
Matrix metalloproteinase-2 and -9 levels in obese patientsG Derosa, I Ferrari, A D'Angelo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: a dose-finding studyG Frasci, N Panza, P Comella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancerR V Iaffaioli, A Tortoriello, G Facchini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-ItaliaG Frasci, P Comella, N Panza, et al.
Cancer|August 16, 2001
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)H S Parra, L Tixi, F Latteri, et al.
Pageof 7